Page 336 - Read Online

Page 22 of 23 Monks et al. J Cancer Metastasis Treat 2019;5:24 I http://dx.doi.org/10.20517/2394-4722.2018.79

162. Tang CH, Chiu YC, Tan TW, Yang RS, Fu WM. Adiponectin enhances IL-6 production in human synovial fibroblast via an AdipoR1
receptor, AMPK, p38, and NF-kappa B pathway. J Immunol 2007;179:5483-92.
163. Fan D, Li L, Wang C, Cui XB, Zhou Y, et al. Adiponectin induces interleukin-6 production and its underlying mechanism in adult rat cardiac
fibroblasts. J Cell Physiol 2011;226:1793-802.
164. Couper KN, Blount DG, Riley EM. IL-10: the master regulator of immunity to infection. J Immunol 2008;180:5771-7.
165. Melillo JA, Song L, Bhagat G, Blazquez AB, Plumlee CR, et al. Dendritic Cell (DC)-Specific Targeting Reveals Stat3 as a Negative
Regulator of DC Function. J Immunol 2010;184:2638-45.
166. Williams L, Bradley L, Smith A, Foxwell B. Signal transducer and activator of transcription 3 is the dominant mediator of the anti-
inflammatory effects of IL-10 in human macrophages. J Immunol 2004;172:567-76.
167. El Kasmi KC, Smith AM, Williams L, Neale G, Panopoulos AD, et al. Cutting edge: A transcriptional repressor and corepressor induced by
the STAT3-regulated anti-inflammatory signaling pathway. J Immunol 2007;179:7215-9.
168. Folco EJ, Rocha VZ, López-Ilasaca M, Libby P. Adiponectin inhibits Pro-inflammatory signaling in human macrophages independent of
interleukin-10. J Biol Chem 2009;284:25569-75.
169. Ohashi K, Parker JL, Ouchi N, Higuchi A, Vita JA, et al. Adiponectin promotes macrophage polarization toward an anti-inflammatory
phenotype. J Biol Chem 2010;285:6153-60.
170. Ouchi N, Kobayashi H, Kihara S, Kumada M, Sato K, et al. Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-
activated protein kinase and Akt signaling in endothelial cells. J Biol Chem 2004;279:1304-9.
171. Ohashi K, Kihara S, Ouchi N, Kumada M, Fujita K, et al. Adiponectin replenishment ameliorates obesity-related hypertension. Hypertension
2006;47:1108-16.
172. Shibata R, Ouchi N, Ito M, Kihara S, Shiojima I, et al. Adiponectin-mediated modulation of hypertrophic signals in the heart. Nat Med
2004;10:1384-9.
173. Denzel MS, Scimia MC, Zumstein PM, Walsh K, Ruiz-Lozano P, et al. T-cadherin is critical for adiponectin-mediated cardioprotection in
mice. J Clin Invest 2010;120:4342-52.
174. Ohashi K, Ouchi N, Sato K, Higuchi A, Ishikawa TO, et al. Adiponectin promotes revascularization of ischemic muscle through a
cyclooxygenase 2-dependent mechanism. Mol Cell Biol 2009;29:3487-99.
175. Masaie H, Oritani K, Yokota T, Takahashi I, Shirogane T, et al. Adiponectin binds to chemokines via the globular head and modulates
interactions between chemokines and heparan sulfates. Exp Hematol 2007;35:947-56.
176. Gosset P, Charbonnier AS, Delerive P, Fontaine J, Staels B, et al. Peroxisome proliferator-activated receptor gamma activators affect the
maturation of human monocyte-derived dendritic cells. Eur J Immunol 2001;31:2857-65.
177. Li Y, Chu N, Rostami A, Zahng GX. Dendritic cells transduced with SOCS-3 exhibit a tolerogenic/DC2 phenotype that directs type 2 Th
cell differentiation in vitro and in vivo. J Immunol 2006;177:16779-88.
178. Robbins PD, Morelli AE. Regulation of immune responses by extracellular vesicles. Nat Rev Immunol 2014;14:195-208.
179. Lai RC, Arslan F, Lee MM, Sze NS, Choo A, et al. Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell
Res 2010;4:214-22.
180. Hui X, Gu P, Zhang J, Nie T, Pan Y, et al. Adiponectin enhances cold-induced browning of subcutaneous adipose tissue via promoting M2
macrophage proliferation. Cell Metab 2015;22:279-90.
181. Kyriazi E, Tsiotra PC, Boutati E, Ikonomidis I, Fountoulaki K, et al. Effects of Adiponectin in TNF-α, IL-6, and IL-10 cytokine production
from coronary artery disease macrophages. Horm Metab Res 2011;43:537-44.
182. Mandal P, Pratt BT, Barnes M, McMullen MR, Nagy LE. Molecular mechanism for adiponectin-dependent M2 macrophage polarization. J
Biol Chem 2011;286:13460-9.
183. Gove ME, Pini M, Fayad R, Cabay RJ, Fantuzzi G. Adiponectin deficiency modulates adhesion molecules expression and cytokine
production but does not affect disease severity in the transfer model of colitis. Cytokine 2009;47:119-25.
184. Komura N, Maeda N, Mori T, Kihara S, Nakatsuji H, et al. Adiponectin protein exists in aortic endothelial cells. PLoS One 2013;8:e71271.
185. Park P, McMullen MR, Huang H, Thakur V, Nagy LE. Short-term treatment of RAW264.7 macrophages with adiponectin increases
tumor necrosis factor-α (TNF-α) expression via ERK1/2 activation and Egr-1 expression: role of TNF-alpha in adiponectin-stimulated
interleukin-10 production. J Biol Chem 2007;282:21695-703.
186. Jung MY, Kim HS, Hong HJ, Youn BS, Kim TS. Adiponectin induces dendritic cell activation via PLCγ/JNK/NF-κB pathways, leading to
Th1 and Th17 polarization. J Immunol 2012;188:2592-601.
187. Katsuki A, Sumida Y, Urakawa H, Gabazza EC, Murashima S, et al. Plasma levels of adiponectin are associated with insulin resistance
and serum levels of triglyceride in Japanese metabolically obese, normal-weight men with normal glucose tolerance. Diabetes Care
2003;26:2964-5.
188. Tan PH, Sagoo P, Chan C, Yates JB, Campbell J, et al. Inhibition of NF-kappa B and oxidative pathways in human dendritic cells by
antioxidative vitamins generates regulatory T cells. J Immunol 2005;174:7633-44.
189. Kriketos AD, Gan SK, Poynten AM, Furler SM, Chisholm DJ, et al. Exercise increases adiponectin levels and insulin sensitivity in humans.
Diabetes Care 2004;27:629-30.
190. Chinetti G, Zawadski C, Fruchart JC, Staels B. Expression of adiponectin receptors in human macrophages and regulation by agonists of the
nuclear receptors PPARalpha, PPARgamma, and LXR. Biochem Biophys Res Commun 2004;314:151-8.
191. Tomizawa A, Hattori Y, Kasai K, Nakano Y. Adiponectin induces NF-κB activation that leads to suppression of cytokine-induced NF-κB
activation in vascular endothelial cells: globular adiponectin vs. high molecular weight adiponectin. Diab Vasc Dis Res 2008;5:123-7.
192. Otvos Jr L, Haspinger E, La Russa F, Maspero F, Graziano P, et al. Design and development of a peptide-based adiponectin receptor agonist
for cancer treatment. BMC Biotechnol 2011;11:90.
193. Otvos L Jr, Kovalszky I, Olah J, Coroniti R, Knappe D, et al. Optimization of adiponectin-derived peptides for inhibition of cancer cell
growth and signaling. Biopolymers 2015;104:156-66.